Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Barrows, G. H.
Right arrow Articles by Christopherson, W. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Barrows, G. H.
Right arrow Articles by Christopherson, W. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Human Liver Neoplasia and Steroid Exposure

George H. Barrows, M.D.

Assistant Professor of Pathology, University of Louisville School of Medicine, Louisville, Kentucky 40292 and James Graham Brown Cancer Center, Louisville, Kentucky 40202

E. Truman Mays, M.D.

Clinical Professor of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky 40506

William M. Christopherson, M.D.

Professor of Pathology, University of Louisville School of Medicine, Louisville, Kentucky 40292 and James Graham Brown Cancer Center, Louisville, Kentucky 40202

This study examines experience with over 250 liver tumors in young women. Most were oral contraceptive related. There were two distinct benign liver tumor types: focal nodular hyperplasia and liver cell adenoma. Six benign liver tumors were examined for estrogen receptors. They did not contain significant quantities of estrogen receptor, supporting experimental studies of an epigenetic origin. Multiple tumors occurred in about 20% of cases but did not change the favorable prognosis associated with benign tumors. The most significant source of morbidity and mortality was spontaneous hemorrhage or rupture. Twenty-three women in this series had hepatocellular carcinoma and the majority of these were associated with prolonged steroid usage. These malignant liver tumors occurred in young females without cirrhosis or other factors known to be associated with hepatic malignancy. Unlike "hepatocellular carcinomas" reported in males taking anabolic androgenic steroids, the tumors in females had a high rate of metastasis to a variety of organs. The risk of liver tumors in oral contraceptive users remains unknown, but must be very small since an estimated 150 million women worldwide and 40 million in the U.S.A. have used oral contraceptives.

  • 1. Baum JK, Bookstein JJ, Holtz F, Klein EW: Possible association between hepatomas and oral contraceptives. Lancet 9: 926–929, 1973.
  • 2. Sturtevant FM: Oral contraceptives and liver tumors in Controversies in Contraception. Moghissi KS (editor). Williams and Wilkins, Baltimore, 1979, Chapter 7.
  • 3. Klatskin G: Hepatic tumors: Possible relationship to use of oral contraceptives. Gastroenterology 73: 386–394, 1977.[Web of Science][Medline] [Order article via Infotrieve]
  • 4. Caroli J, Paraf A, Charbonnier A, Vallin J: Implantations d'oestrogenese apparement suivies d'un cancer primitif du foie. Rev Intern Hepatol 3: 497, 1953.
  • 5. Christopherson WM, Mays ET, Barrows GH: Liver tumors in women on contraceptive steroids. J Obstet Gynecol 46: 221–223, 1975.
  • 6. Neuberger J, Nunnerley HB, Davis M, Portman B, Laws JR, Williams R: Oral contraceptive-associated liver tumours: Occurrence of malignancy and difficulties in diagnosis. Lancet 1: 263, 1980.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 7. Christopherson WM, Mays ET, Barrows GH: Liver tumors in young women: A clinical pathologic study of 201 cases in the Louisville registry in Progress in Surgical Pathology vol 2. Fenoglio CM, Wolff M (editors). Masson Publishing USA, New York, 1980, pp. 187–205.
  • 8. Nissen ED, Kent DR, Nissen SE: Role of oral contraceptive agents in the pathogenesis of liver tumors in Liver Carcinogenesis. Lapis K, and Johannessen JV (editors). Hemisphere Publishing, New York, 1979, p. 61.
  • 9. Foster JH, Berman MM Solid Liver Tumors, WB Saunders, Philadelphia, 1977.
  • 10. Barrows GH, Christopherson WM, Drill VA: Liver lesions and oral contraceptives. J Toxicol Environ Health 3: 219–230, 1977.[Web of Science][Medline] [Order article via Infotrieve]
  • 11. Reznik-Schuller H: Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 62: 1083–1088, 1979.[Web of Science][Medline] [Order article via Infotrieve]
  • 12. Schardein JL, Kaump DH, Woosley ET, Jellema MM: Long term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxicol Appl Pharmacol 16: 10, 1970.[CrossRef][Medline] [Order article via Infotrieve]
  • 13. Lang R, Redmann U: Nonmutagenicity of some sex hormones in the Ames Salmonella/microsome mutagenicity test. Mutat Res 67: 361–365, 1979.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 14. Reuber MD: Influence of hormones on N-2-fluorenyldicatamide-induced hyperplastic hepatic nodules in rats. J Natl Cancer Inst 43: 445–451, 1969.[Web of Science][Medline] [Order article via Infotrieve]
  • 15. Taper HS: The effect of estradiol-17-phenylpropionate and estradiol benzoate on n-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats. Cancer 42: 462–467, 1978.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 16. Yager JD, Yager R: Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680–3685, 1980.[Abstract/Free Full Text]
  • 17. Wanless IR, Medline A: Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46: 313–320, 1982.[Web of Science][Medline] [Order article via Infotrieve]
  • 18. Christopherson WM, Mays ET: Liver tumors and contraceptive steroids. Experience with the first one hundred registry patients. J Natl Cancer Inst 58: 167–172, 1977.[Web of Science][Medline] [Order article via Infotrieve]
  • 19. Barrows GH, Christopherson WM: Human liver tumors in relation to steroid usage. Perspectives in Environmental Health (In press, 1982).
  • 20. Palmer PE, Christopherson WM, Wolfe HJ: Alpha1-antitrypsin, protein marker in oral contraceptive associated liver tumors. Am J Clin Pathol 68: 736–739, 1977.[Web of Science][Medline] [Order article via Infotrieve]
  • 21. Barrows GH, Christopherson WM, Mays ET, Reese D: Estrogen and progesterone receptor status of benign liver tumors. Am J Clin Pathol 75: 872–873, 1981.
  • 22. Sturtevant FM: Liver tumors and oral contraceptives. Pan-American Conference on Fertility and Sterility, Dorado Beach, Puerto Rico, February 4–12, 1977.
  • 23. Lee S, Chen C: Liver microsomes dimethylate mestranol and some of its effects on drug metabolism. Steroids 18: 565–575, 1971.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 24. Rooks JB, Howard HW, Ishak KG, Strauss LT, Greenspan JR, Paganini A, Tyler CW: Epidemiology of hepatocellular adenoma. J A M A 242: 644–648, 1979.[CrossRef][Medline] [Order article via Infotrieve]
  • 25. Grabowski M, Stenram U, Vergvist A: Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta Pathol Microbiol Scand Sect A 88: 615–622, 1975.
  • 26. Edmondson HA, Reynolds TB, Henderson B, Benton B: Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86: 180–182, 1977.[Abstract/Free Full Text]
  • 27. Ross D, Pina J, Mirza M, Galvan A, Ponce L: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. Ann Intern Med 85: 203–204, 1976.[Abstract/Free Full Text]
  • 28. Jensen EV, DeSombre ER: Estrogen-receptor interaction. Science 182: 126–133, 1973.[Abstract/Free Full Text]
  • 29. Irey NS, Norris HJ: Intimal vascular lesions associated with female reproductive steroids. Arch Pathol 96: 227–234, 1973.[Web of Science][Medline] [Order article via Infotrieve]
  • 30. Almen T, Hartel M, Nylander G, Olivecronah J: The effect of estrogen on the vascular endothelium and its possible relation to thrombosis. Surg Gynecol Obstet 140:938–940, 1975.[Web of Science][Medline] [Order article via Infotrieve]
  • 31. Howell RR, Stevenson RE, Ben-Menachem Y, Phyliky RL, Berry DH: Hepatic adenomata with type I glycogen storage disease. J A M A 236: 1481–1484, 1976.[CrossRef][Medline] [Order article via Infotrieve]
  • 32. Weil R, Koep LJ, Starzl TE: Liver resection for hepatic adenoma. Arch Surg 114: 178–180, 1979.[Abstract/Free Full Text]
  • 33. Farrell GC, Joshua DE, Uren RF, Baird PJ, Perkins KW, Kronenberg H: Androgen-induced hepatoma. Lancet 1: 430–432, 1975.[Web of Science][Medline] [Order article via Infotrieve]
  • 34. Johnson FL, Feagler JR, Lerner KG, Majerus PW, Siegel M, Hartmann JR, Thomas ED: Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet II: 1273–1276, 1972.
  • 35. Davis M, Portman B, Searle M, Wright R, Williams R: Histologic evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 4: 496–498, 1975.[Abstract/Free Full Text]
  • 36. Galloway SJ, Casarella WS, Lattes R, Seaman W: Minimal deviation hepatoma: A new entity. Am J Roentgenol 125: 184–192, 1975.[Abstract]
  • 37. Okuda K, Peters RI: Hepatocellular Carcinoma. John Wiley and Sons, New York, 1976, p. 152.
  • 38. Berman MM, Libbey NP, Foster JH: Hepatocellular carcinoma. Polygonal cell type with fibrous stroma-an atypical variant with a favorable prognosis. Cancer 46: 1448–1455, 1980.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 39. Christopherson WM: Possible etiologic factors for some malignant hepatic tumors in Gastrointestinal Cancer. Stroehlein JR, Romsdahl MM (editors). Raven Press, New York, 1981, pp. 257–269.
  • 40. Ory WM, Rosenfield A, Landrum LC: The pill at 20: An assessment. Fam Plann Perspect 12: 278–283, 1980.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 10, No. 2, 145-149 (1982)
DOI: 10.1177/019262338201000226
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Barrows, G. H.
Right arrow Articles by Christopherson, W. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Barrows, G. H.
Right arrow Articles by Christopherson, W. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?